Turkey Firms Up More Positive Policies As It Seeks Biotech Boost
This article was originally published in PharmAsia News
Executive Summary
Having prepared a Biotechnology Strategy Document and Action Plan last year, Turkey now seems to have a roadmap in this sector. The blueprint includes many policies that the research-based pharmaceutical industry has been advocating for at least 10 years, such as promoting biotech investments through legal reforms to strengthen intellectual property rights and boosting transparent and predictable public policies for market access and reimbursement.